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-J-and modified by Pappenhelmer et al. and Rail et al. 16 has provided quantitative measurements of spinal fluid production and absorption in the experimental animal. However, considerable controversy still exists concening these parameters in the human. 4,14,1s The availability at the National institutes of Health of a group of patients undergoing cerebrospinal fluid perfusion chemotherapy for the treatment of central nervous system neoplasm afforded the opportunity for the study of spinal fluid production and absorption. It was further felt that the availability of baseline figures would provide an ideal setting for the investigation of agents reported to affect spinal fluid production.
Acetazolamide (Diamox| * a carbonic anhydrase inhibitor, has been advocated for the clinical reduction of spinal fluid production. a,5 However, documentation of the effect has been hindered by lack of controlled data, as well as by variations in route and dosage.l,9,10, TM The following report presents data for human spinal fluid production and its modification by acetazolamide.
Methods
Eleven patients with central nervous system neoplasms (gliomas or meningeal leukemia) were perfused from ventricle to lumbar subarachnoid space, or from one ventricle to the ipsilateral or contralateral ventricle. The details of patient selection and perfusion have previously been described. 17 Intracranial pressure was maintained at the specified levels by varying the height of the outflow cannula. All perfusions were carried out with Elliott's B~ solution. Carboxy-14C inulin Received for publication January 6, 1966 Calculations. Spinal fluid production was calculated according to the equation of Heisey, Held, and Pappenheimer s as follows :
csf=cerebrospinal fluid production ml./min. r = rate ml./min. c = concentration (quantity/ml.) i,o = inflow or outflow csf = ri(ci--co) /Co These calculations assume that there is no inulin in newly formed spinal fluid. Spinal fluid then mixes with perfusate diluting the inulin concentration. The loss of fluid in bulk through any natural pathway distal to the perfusion route will not influence calculated spinal fluid production. Bulk flow is defined as the unselective and unchanged loss of fluid with all its constituents. It can be calculated as inulin clearance or for the purpose of studying water loss simply as inflow /min.-outflow/min. A steady state production level was achieved for each perfusion before experimental modifications were imposed.
Results
Lumbar-Subarachnoid Perfusions (zero outflow pressure, i.e. outflow at right heart level) ( Table 1 ). These perfusions drain the total ventricular and subarachnoid space and provide a true measure of fluid production from all sources. Eight perfusions at zero outflow pressure were carried out on 3 patients whose ages were 1~, 14, and 50 respectively. The average spinal fluid production was approximately 0.37 ml./min. Perfusions All Other Routes (zero outflow pressure). Draining the ventricular space at pressures below venous pressure should result in complete equilibration of inulin containing perfusate and all the produced spinal fluid. To test this hypothesis, perfusions carried out exclusively through one or both ventricles (at zero outflow pressure) were compared with those utilizing the total lumbar-subarachnoid route. Twenty perfusions in 5 patients were performed utilizing inflow and outflow routes within one or both ventricles ( Table 2 ). The average cerebrospinal fluid production for this group was 0.40 + .12 S.D. ml./min. This is in agreement with the figure obtained from ventricular to lumbar subarachnoid perfusions and supports the assumption that these modified routes under conditions of low outflow pressure provide valid measurements of total spinal fluid production. (Table 3 ). In the supine patient undergoing cerebrospinal fluid space perfusion, raising the outflow cannula above central venous (Fig. 1 ). It appears that with the increased outflow pressure, 4th ventricular fluid flows posteriorly into the lumbar sac and over the cortex rather than into the lateral ventricle where it would mix with perfusate as in the zero outflow pressure experiments. The average production figure for the 5 experiments performed at outflow pressure below central venous pressure was 0.3~+.1 S.D. ml./min.
Effects of Elevated Intracranial Pressure
A more critical look at the effect of increased pressure is provided by comparing several perfusions in the same patient, utilizing the same route but varying the pressure. In patient L.G., spinal fluid production for a perfusion at zero pressure (Table 1) and one in which the pressure was gradually increased from 90 ram. to ~40 mm. was 0.~7 ml./min. and 0.17 ml./min, respectively (Tables 1 and  3 ). In another perfusion on the same patient the spinal fluid pressure was raised stepwise from 90 ram. to ~40 mm. and no change in production rate was noted (Table 4) . When perfusions from patient D.B. or P.McN. were compared in either negative or positive pressure ranges so that 4th ventricular fluid was either included or excluded, no consistent pressure correlated effect on spinal fluid production was noted. In patient F.B., the perfusion route was from a tumor cavity to the ipsilateral ventricle and the pressure was increased stepwise from 0 to ~50 mm. H20 allowing 30 minutes after each increment for equilibration. No variation in spinal fluid production was found to occur with pressure changes (Table 4) . It is recognized that, as the outflow pressure was raised, more fluid (perfusate and cerebrospinal fluid) would be forced through the foramen of Monro and be lost distal to the perfusion route. However, the concentration of inulin in the fluid as it exists via the foramen of Monro should be the same as the inulin concentration recovered in the outflow; therefore, this calculation of spinal fluid should be unaffected by this loss of fluid in bulk.
Bulk Flow of Spinal Fluid. When bulk flow is calculated as the difference between inflow and outflow volume for ~5 perfusions in 8 patients and plotted against pressure in ram. H20, it is found that bulk flow is directly proportional to pressure within the range 0 to 100 ram. H20. From 100 to 160 ram. H20 bulk flow does not increase (Fig. ~) . Figures for bulk flow at zero outflow pressure were taken only from patients who subsequently were perfused at higher pressure (Table 5) . It is realized that various perfusion routes were utilized in this series; however, all these patients had radiographically patent ventricular-subaraehnoid communications and, 
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Spinal fluid production as a function of pressure Fie. 2. "Bulk" flow (inflow-outflow) as a function of outflow pressure. was measured in some cases as long as 3 hours after Diamox | infusion. One patient, A.M., in 3 out of 8 experiments demonstrated a 50 to 60 per cent reduction in cerebrospinal fluid production. The maximum decrease in all 8 instances was recorded during the period 60 to 90 minutes after acetazolamide infusion. H.W. demonstrated a ~1 per cent reduction in the 90-minute postacetazolamide period in only 1 of 5 experiments. However, in all but one of the experiments showing a transient reduction in cerebrospinal fluid production, this occurred within the first 80 minutes; in one experiment it occurred 90 minutes after drug administration. The 8rd patient, F.B., during one experiment had a 48 per cent increase in cerebrospinal fluid production in the 90-minute period following drug infusion. Three patients received 800 to 500 rag. of acetazolamide I.V. and all experienced a decrease in cerebrospinal fluid production. This varied from 6 per cent to 50 per cent (A.M.) of the pre-drug level and all had a maximum decrease in the 60-to 90-minute period following drug administration. In 7 out of 10 experiments the post-acetazolamide spinal fluid production rate reached the pre-perfusion rate within ~ hours of drug administration.
Discussion
Previous methods of determining human cerebrospinal fluid production have depended on measurements of the volume of cerebrospinal fluid collected or the time required for the restoration of cerebrospinal fluid pressure after the withdrawal of a given __No. The inulin dilution technique is unaffected by loss in bulk of spinal fluid and should, therefore, provide a good estimate for "fluid" production. In this study it is recognized that all patients had malignancies of the central nervous system. The composite figure of 0.37+.1 S.D. ml./min., however, is in close agreement with the majority of the studies in the literature. 4 The data suggest that cerebrospinal fluid production is independent of intracranial pressure. This is consistent with the findings of Heisey et al. s in their studies in the goat. There seems to be no difference in the spinal fluid production of children and adults. However, the data presented do not include either infants or the aged. Bulk flow of spinal fluid in humans seems to be directly related to intracranial pressure (or the intracranial pressure minus sagittal sinus pressure). This is also consistent with animal data. 2,s The human data, however, suggest a maximum bulk flow of about 1.8 ml./min. This will have to be verified by further experiments at higher intracranial pressures. The possibility exists that high intracranial pressures may compress the exit pathways known to exist within the arachnoidal villi. It is of great importance to note that bulk flow can account for the resorption of at least a fluid volume equivalent to 4 times normal spinal fluid production. Further quantative studies of both production and resorption of spinal fluid may prove helpful in understanding the pathogenesis of communicating hydrocephalus. Both increases and decreases in spinal fluid production have been attributed to acetazolamide. 1,3,5,9,1~ The differences no doubt result from differences in method, route of administration, dosage, and the experimental animal. In our series, under conditions of regulated intracranial pressure, acetazolamide administered intravenously was found to decrease cerebrospinal fluid production in the human. The degree of response varied in individual test subjects. The maximum response was always achieved within the first 90 minutes and the duration of response was not longer than 30 minutes. The variability of the acetazolamide response in humans may account for its lack of critical success in the treatment of hydrocephalus.
The quantitative comparisons of spinal fluid production and bulk flow suggest that the emphasis of future studies on the pathogenesis of hydrocephalus and clinical evaluation of the hydrocephalic patient be shifted from spinal fluid production to bulk flow pathways.
Summary
Spinal fluid production and absorption was measured in a group of patients with malignancies of the nervous system. The findings were as follows:
1. Spinal fluid production averaged 0.37 ml./min. ~. Spinal fluid production was unaffected by intracranial pressure or the age of the subject (from puberty to fifth decade). 3. The rate of absorption in bulk of fluid from the subaraehnoid space was directly proportional to intracranial pressure within the range of 0 to 100 ram.
H20. 4 . Absorption capacity exceeded spinal fluid production by at least 4-fold. 5. Intravenous acetazolamide caused a reduction in spinal fluid production.
